Bases Neurobiológicas y Psicológicas de los Trastornos Mentales. Trastornos del Neurodesarrollo

Addington, J; Liu, L; Braun, A; Auther, A; Calkins, ME; Cornblatt, BA; Corcoran, CM; Fusar-Poli, P; Kerr, MJ; Mourgues-Codern, CV; Nunez, AR; Oliver, D; Strauss, GP; Walsh, BC; Alameda, LK; Arango, C; Breitborde, NJK; Broome, MR; Cadenhead, KS; Carrion, RE; Chen, EYH; Choi, J; Coleman, MJ; Conus, P; Diaz-Caneja, CM; Dwyer, D; Ellman, LM; Faghankhani, M; Gaspar, PA; Gerber, C; Glenthoj, LB; Horton, LE; Hui, C; Jacobs, GR; Kambeitz, J; Kambeitz-Ilankovic, L; Keshavan, MS; Kim, SW; Koutsouleris, N; Kwon, JS; Langbein, K; Lewandowski, KE; Mamah, D; Marcy, PJ; Mathalon, DH; Mittal, VA; Nordentoft, M; Pearlson, GD; Penzel, N; Perez, J; Perkins, DO; Powers, AR III; Rogers, J; Sabb, FW; Schiffman, J; Shah, JL; Silverstein, SM; Smesny, S; Stone, WS; Thompson, A; Thompson, JL; Upthegrove, R; Verma, S; Wang, JJ; Wastler, HM; Wickham, A; Winter-van Rossum, I; Wolf, DH; Bouix, S; Pasternak, O; Kahn, RS; Bearden, CE; Kane, JM; McGorry, PD; Buccilli, K; Nelson, B; Shenton, ME; Woods, SW; Yung, AR.

Sample ascertainment and clinical outcome measures in the Accelerating Medicines Partnership® Schizophrenia Program

Schizophrenia. 2025; 11(1): Nº de citas: 3 [doi:10.1038/s41537-025-00556-7]

Harms, MP; Cho, KIK; Anticevic, A; Bolo, NR; Bouix, S; Campbell, D; Cannon, TD; Cecchi, G; Goncalves, M; Haidar, A; Hughes, DE; Izyurov, I; John, O; Kapur, T; Kim, N; Kotler, E; Kubicki, M; Kuperman, JM; Laulette, K; Lindberg, U; Markiewicz, C; Ning, LP; Poldrack, RA; Rathi, Y; Romo, PA; Tamayo, Z; Wannan, C; Wickham, A; Yassin, W; Zhou, JH; Addington, J; Alameda, L; Arango, C; Breitborde, NJK; Broome, MR; Cadenhead, KS; Calkins, ME; Chen, EYH; Choi, J; Conus, P; Corcoran, CM; Cornblatt, BA; Diaz-Caneja, CM; Ellman, LM; Fusar-Poli, P; Gaspar, PA; Gerber, C; Glenthoj, LB; Horton, LE; Hui, CLM; Kambeitz, J; Kambeitz-Ilankovic, L; Keshavan, MS; Kim, SW; Koutsouleris, N; Kwon, JS; Langbein, K; Mamah, D; Mathalon, DH; Mittal, VA; Nordentoft, M; Pearlson, GD; Perez, J; Perkins, DO; Powers, AR; Rogers, J; Sabb, FW; Schiffman, J; Shah, JL; Silverstein, SM; Smesny, S; Stone, WS; Strauss, GP; Thompson, JL; Upthegrove, R; Verma, SK; Wang, JJ; Wolf, DH; Kahn, RS; Kane, JM; McGorry, PD; Nelson, B; Woods, SW; Shenton, ME; Wood, SJ; Bearden, CE; Pasternak, O.

The MR neuroimaging protocol for the Accelerating Medicines Partnership® Schizophrenia Program

Schizophrenia. 2025; 11(1): Nº de citas: 2 [doi:10.1038/s41537-025-00581-6]

Szmulewicz, AG; Martinez-Alés, G; Logan, R; Joober, R; Ferrara, M; Kelly, C; Fredrikson, D; Thorpe, LE; Conderino, S; Díaz-Caneja, CM; Srihari, V; Yatham, LN; Sarpal, DK; Shinn, AK; Arango, C; Shah, JL; Öngür, D; Hernán, MA.

Comparative effectiveness of long-acting injectable versus oral antipsychotic medication after a first episode of psychosis

Nature Mental Health. 2025; 3(4): [doi:10.1038/s44220-025-00407-5]

Solmi M; Thompson T; Cortese S; Estradé A; Agorastos A; Radua J; Dragioti E; Vancampfort D; Thygesen LC; Aschauer H; Schlögelhofer M; Aschauer E; Schneeberger AA; Huber CG; Hasler G; Conus P; Do Cuénod KQ; von Känel R; Arrondo G; Fusar-Poli P; Gorwood P; Llorca PM; Krebs MO; Scanferla E; Kishimoto T; Rabbani G; Skonieczna-Zydecka K; Brambilla P; Favaro A; Takamiya A; Zoccante L; Colizzi M; Bourgin J; Kaminski K; Moghadasin M; Seedat S; Matthews E; Wells J; Vassilopoulou E; Gadelha A; Su KP; Kwon JS; Kim M; Lee TY; Papsuev O; Manková D; Boscutti A; Gerunda C; Saccon D; Righi E; Monaco F; Croatto G; Cereda G; Demurtas J; Brondino N; Veronese N; Enrico P; Politi P; Ciappolino V; Pfennig A; Bechdolf A; Meyer-Lindenberg A; Kahl KG; Domschke K; Bauer M; Koutsouleris N; Winter S; Borgwardt S; Bitter I; Balazs J; Czobor P; Unoka Z; Mavridis D; Tsamakis K; Bozikas VP; Tunvirachaisakul C; Maes M; Rungnirundorn T; Supasitthumrong T; Haque A; Brunoni AR; Costardi CG; Schuch FB; Polanczyk G; Luiz JM; Fonseca L; Aparicio LV; Valvassori SS; Nordentoft M; Vendsborg P; Hoffmann SH; Sehli J; Sartorius N; Heuss S; Guinart D; Hamilton J; Kane J; Rubio J; Sand M; Koyanagi A; Solanes A; Andreu-Bernabeu A; San José Cáceres A; Arango C; Díaz-Caneja CM; Hidalgo-Mazzei D; Vieta E; Gonzalez-Peñas J; Fortea L; Parellada M; Fullana MA; Verdolini N; Andrlíková E; Janku K; Millan MJ; Honciuc M; Moniuszko-Malinowska A; Loniewski I; Samochowiec J; Kiszkiel L; Marlicz M; Sowa P; Marlicz W; Spies G; Stubbs B; Firth J; Sullivan S; Darcin AE; Aksu H; Dilbaz N; Noyan O; Kitazawa M; Kurokawa S; Tazawa Y; Anselmi A; Cracco C; Machado AI; Estrade N; De Leo D; Curtis J; Berk M; Carvalho AF; Ward P; Teasdale S; Rosenbaum S; Marx W; Horodnic AV; Oprea L; Alexinschi O; Ifteni P; Turliuc S; Ciuhodaru T; Bolos A; Matei V; Nieman DH; Sommer I; van Os J; van Amelsvoort T; Sun CF; Guu TW; Jiao C; Zhang J; Fan J; Zou L; Yu X; Chi X; de Timary P; van Winkel R; Ng B; Pena E; Arellano R; Roman R; Sanchez T; Movina L; Morgado P; Brissos S; Aizberg O; Mosina A; Krinitski D; Mugisha J; Sadeghi-Bahmani D; Sheybani F; Sadeghi M; Hadi S; Brand S; Errazuriz A; Crossley N; Ristic DI; López-Jaramillo C; Efthymiou D; Kuttichira P; Kallivayalil RA; Javed A; Afridi MI; James B; Seb-Akahomen OJ; Fiedorowicz J; Daskalakis J; Yatham LN; Yang L; Okasha T; Dahdouh A; Tiihonen J; Shin JI; Lee J; Mhalla A; Gaha L; Brahim T; Altynbekov K; Negay N; Nurmagambetova S; Jamei YA; Weiser M; Correll CU.

Collaborative Outcomes Study on Health and Functioning During Infection Times (COH-FIT): Global and Risk-Group Stratified Course of Well-Being and Mental Health During the COVID-19 Pandemic in Adolescents.

JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY. 2025; 64(4): 499-519 Nº de citas: 2 [doi:10.1016/j.jaac.2024.07.932]

Vieta, E; Ahmed, N; Arango, C; Cleare, AJ; Demyttenaere, K; Dold, M; Ito, T; Kambarov, Y; Krüger, S; Llorca, PM; Mcintyre, RS; Sani, G; von Holt, C; Rive, B.

Improvements in functioning and workplace productivity with esketamine nasal spray versus quetiapine extended release in patients with treatment resistant depression: Findings from a 32-week randomised, open-label, rater-blinded phase IIIb study

EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2025; 93: 29-39 Nº de citas: 1 [doi:10.1016/j.euroneuro.2024.12.013]

Dominguez-Alonso, S; Tubio-Fungueiriño, M; Gonzalez-Peñas, J; Fernandez-Prieto, M; Parellada, M; Arango, C; Carracedo, A; Rodriguez-Fontenla, C.

Alternative splicing analysis in a Spanish ASD (Autism Spectrum Disorders) cohort: in silico prediction and characterization

Scientific Reports. 2025; 15(1): [doi:10.1038/s41598-025-95456-2]

Allott, K; Yassin, W; Alameda, L; Billah, T; Borders, O; Buccilli, K; Carrión, RE; Castillo-Passi, RI; Cho, KIK; Chin, K; Coleman, MJ; Colton, BL; Corral, S; Dwyer, D; Gundersen, KB; Gur, RC; Hoftman, GD; Jacobs, GR; Kelly, S; Lewandowski, KE; Marcy, PJ; Matneja, P; Mclaughlin, D; Nunez, AR; Parsa, S; Penzel, N; Ray, S; Reinen, JM; Ruparel, K; Sand, MS; Santorelli, G; Seitz-Holland, J; Spark, J; Tamayo, Z; Thompson, A; Tod, S; Wannan, CMJ; Wickham, A; Wood, SJ; Zoupou, E; Addington, J; Anticevic, A; Arango, C; Breitborde, NJK; Broome, MR; Cadenhead, KS; Calkins, ME; Chen, EYH; Choi, J; Conus, P; Corcoran, CM; Cornblatt, BA; Ellman, LM; Fusar-Poli, P; Gaspar, PA; Gerber, C; Glenthoj, LB; Horton, LE; Hui, CLM; Kambeitz, J; Kambeitz-Ilankovic, L; Keshavan, M; Kim, SW; Koutsouleris, N; Kwon, JS; Langbein, K; Mamah, D; Diaz-Caneja, CM; Mathalon, DH; Mittal, VA; Nordentoft, M; Pearlson, GD; Perkins, DO; Perez, J; Powers, AR III; Rogers, J; Sabb, FW; Schiffman, J; Shah, JL; Silverstein, SM; Smesny, S; Strauss, GP; Thompson, JL; Upthegrove, R; Verma, SK; Wang, JJ; Wolf, DH; Pasternak, O; Bouix, S; Mcgorry, PD; Kane, JM; Kahn, RS; Bearden, CE; Shenton, ME; Woods, SW; Nelson, B; Accelerating Med Partnership; Stone, WS.

Cognitive assessment in the Accelerating Medicines Partnership® Schizophrenia Program: harmonization priorities and strategies in a diverse international sample

Schizophrenia. 2025; 11(1): Nº de citas: 4 [doi:10.1038/s41537-025-00578-1]

Andrés-Camazón, P; Diaz-Caneja, CM; Ballem, R; Chen, JY; Calhoun, VD; Iraji, A.

Neurobiology-based cognitive biotypes using multi-scale intrinsic connectivity networks in psychotic disorders

Schizophrenia. 2025; 11(1): [doi:10.1038/s41537-025-00593-2]

Díaz-Ruíz, R; Poca, M; Román, E; Cuyàs, B; Bañares, I; Morales, A; Martínez-Esparza, EH; Panadero, R; Velasco, C; Rapado-Castro, M; Bretón, I; Banares, R; Soriano, G; García-Martínez, R.

Treatment of Vitamin D Deficiency in Decompensated Patients with Cirrhosis Is Associated with Improvement in Frailty

Medical Sciences. 2025; 13(1): Nº de citas: 1 [doi:10.3390/medsci13010030]

Chart-Pascual, JP; Goena, J; Lara, F; Torres, MM; Napal, JM; Muñoz, R; Montero, CG; Martínez, OF; Ortega, MA; de Pablo, GS; Pinto, AG; Quintero, J; Alvarez-Mon, M; Alvarez-Mon, MA.

Understanding social media discourse on antidepressants: unsupervised and sentiment analysis using X

EUROPEAN PSYCHIATRY. 2025; 68(1): [doi:10.1192/j.eurpsy.2025.10]

Aymerich C; Bullock E; Rowe SMB; Catalan A; Salazar de Pablo G.

Aggressive Behavior in Children and Adolescents With Bipolar Spectrum Disorder: A Systematic Review of the Prevalence, Associated Factors, and Treatment.

Jaacap Open. 2025; 3(1): 42-55 [doi:10.1016/j.jaacop.2024.02.009]

Fernández, AG; Brenlla, E; Caro-Cañizares, I; Esteban, AC; Carballo, JJ.

Adolescent Females as a Group Particularly Vulnerable to Suicide Risk and Traumatic Stressful Life Events

EARLY INTERVENTION IN PSYCHIATRY. 2025; 19(3): [doi:10.1111/eip.70022]

Gil-Berrozpe, GJ; Segura, AG; Sánchez-Torres, AM; Amoretti, S; Giné-Servén, E; Vieta, E; Mezquida, G; Lobo, A; Gonzalez-Pinto, A; Andreu-Bernabeu, A; Roldán, A; Forte, MF; Castro, J; Bergé, D; Rodríguez, N; Ballesteros, A; Mas, S; Cuesta, MJ; Bernardo, M; PEPs Grp.

Interrelationships between polygenic risk scores, cognition, symptoms, and functioning in first-episode psychosis: A network analysis approach

EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2025; 92: 52-61 [doi:10.1016/j.euroneuro.2024.12.002]

Bioque, M; Llorca-Bofi, V; MacDowell, KS; Amoretti, S; Mezquida, G; Cuesta, MJ; Diaz-Caneja, CM; Ibáñez, A; Segarra, R; González-Pinto, A; Roldán, A; Sáiz, PA; Mané, A; Lobo, A; Martínez-Pinteño, A; Cano-Escalera, G; Berrocoso, E; Bernardo, M.

Impact of Relapse in BDNF Receptors Expression in Patients With a First Episode of Schizophrenia

SCHIZOPHRENIA BULLETIN. 2025; : [doi:10.1093/schbul/sbaf012]

Ferraro, L; Di Forti, M; La Barbera, D; La Cascia, C; Morgan, C; Tripoli, G; Jongsma, H; Seminerio, F; Sartorio, C; Sideli, L; Tarricone, I; Carloni, AL; Szoke, A; Pignon, B; Bernardo, M; de Haan, L; Arango, C; Velthorst, E; Gayer-Anderson, C; Kirkbride, J; Rutten, BPF; Lasalvia, A; Tosato, S; Del Ben, CM; Menezes, PR; Bobes, J; Arrojo, M; Tortelli, A; Jones, P; Selten, JP; van Os, J; Murray, R; Quattrone, D; Vassos, E.

Cognitive presentation at psychosis onset through premorbid deterioration and exposure to environmental risk factors

PSYCHOLOGICAL MEDICINE. 2025; 55: Nº de citas: 1 [doi:10.1017/S0033291724003507]

de-la-Higuera-Gonzalez, P; Rodriguez-Toscano, E; Diaz-Carracedo, P; Gonzalez-Urrea, MJ; Padilla-Quiles, G; Diaz-Marsa, M; de la Torre-luque, A.

Memory deficits in children and adolescents with a psychotic disorder: a systematic review and meta-analysis

EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE. 2025; 275(3): 715-732 [doi:10.1007/s00406-025-01961-w]

Ortiz, M; Pueyo, A; Dongil, FJ; Boquete, L; Sánchez-Morla, EM; Barea, R; Miguel-Jimenez, JM; López-Dorado, A; Vilades, E; Rodrigo, MJ; Cordon, B; Garcia-Martin, E.

New Method of Early RRMS Diagnosis Using OCT-Assessed Structural Retinal Data and Explainable Artificial Intelligence

Translational Vision Science & Technology. 2025; 14(2): Nº de citas: 1 [doi:10.1167/tvst.14.2.14]

Stringaris, A; Burman, C; Delpech, R; Uher, R; Bhudia, D; Miliou, D; Rokas, IM; Kyriakopoulos, M; Foulkes, L; Moreno, C; Cortese, S; Lewis, G; Krebs, G.

Comparing apples and oranges in youth depression treatments? A quantitative critique of the evidence base and guidelines

Bmj Mental Health. 2025; 28(1): Nº de citas: 1 [doi:10.1136/bmjment-2024-301162]